n-acetyl-demethylmuramyl-alanyl-isoglutamine has been researched along with Benign Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haku, T; Mizuno, K; Nabioullin, R; Nishioka, Y; Ogura, T; Sone, S; Yano, S | 1 |
1 other study(ies) available for n-acetyl-demethylmuramyl-alanyl-isoglutamine and Benign Neoplasms
| Article | Year |
|---|---|
Interleukin-10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Cells, Cultured; Cytotoxicity, Immunologic; Humans; Interferon-gamma; Interleukin-10; Interleukin-4; Macrophages, Alveolar; Monocytes; Neoplasms | 1994 |